Production (Stage)
Zai Lab Limited
ZLAB
$31.32
-$1.18-3.63%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 9.41% | 14.40% | 39.74% | 33.60% | -8.80% |
| Total Depreciation and Amortization | 14.81% | 23.30% | 49.69% | 47.42% | 13.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.24% | 624.25% | -76.92% | -34.58% | 74.76% |
| Change in Net Operating Assets | 38.90% | -126.49% | 204.04% | -94.54% | -76.31% |
| Cash from Operations | 31.53% | -273.86% | 51.47% | 28.16% | -30.05% |
| Capital Expenditure | -57.49% | -1,071.17% | 23.58% | 56.94% | 72.27% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 7,580.90% | -2,451.35% | -133.29% | -100.30% | 108.44% |
| Cash from Investing | 9,806.83% | -2,505.44% | -113.75% | -101.98% | 106.10% |
| Total Debt Issued | 111.18% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 46,544.47% | 832.12% | -92.21% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -22.00% | -- | -- | -- | -- |
| Cash from Financing | -9.27% | 60,411.96% | 3,016.86% | 1,595.11% | 1,323.57% |
| Foreign Exchange rate Adjustments | 119.23% | -197.14% | 53.13% | 98.63% | 91.99% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 881.29% | -25,088.44% | 80.16% | -4.17% | 69.34% |